Clinical trial
Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents
NCT03062033 is registered in ClinicalTrials.gov with Neurocrine Biosciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents
- Lead sponsor
- Neurocrine Biosciences
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 4, 2017
- Completion date
- August 31, 2018
- Enrollment
- 70 (estimated)
- Sites
- 34
Conditions
As the registry lists them; a condition with its own page is linked.